First Generic Version of Generess Fe Launched
Generess Fe, which combines a progestin and estrogen with ferrous fumarate, is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Combination oral contraceptives reduce the risk of becoming pregnant primarily by suppressing ovulation. Other mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.
Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets are chewable. Mylan has begun shipment of this product.
For more information call (800) RX-MYLAN or visit Mylan.com.